M H Thiebot
Overview
Explore the profile of M H Thiebot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
751
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loiseau F, Le Bihan C, Hamon M, Thiebot M
Behav Pharmacol
. 2003 Sep;
14(5-6):447-55.
PMID: 14501257
Convergent data suggest that SP, through the activation of neurokinin1 receptors (NK1-R), may be involved in anxiety. In particular, NK1-R antagonists have been reported to exert anxiolytic-like effects in a...
2.
Beaufour C, Le Bihan C, Hamon M, Thiebot M
Behav Neurosci
. 2001 Mar;
115(1):125-37.
PMID: 11256436
In rats trained in an operant fixed-interval-30-s schedule of food reward (FI-30s), acute exposure to contingent footshock resulted in a response suppression that was released by diazepam (DZP; 4 mg/kg...
3.
Becker C, Thiebot M, Touitou Y, Hamon M, Cesselin F, Benoliel J
J Neurosci
. 2001 Jan;
21(1):262-9.
PMID: 11150343
The involvement of cholecystokinin (CCK) in the mechanisms of stress and/or anxiety was assessed by in vivo microdialysis in rats subjected to a social stress paradigm. During the initial 30...
4.
Chaperon F, Thiebot M
Crit Rev Neurobiol
. 2000 May;
13(3):243-81.
PMID: 10803637
Two subtypes of cannabinoid receptors have been identified to date, the CB1 receptor, essentially located in the CNS, but also in peripheral tissues, and the CB2 receptor, found only at...
5.
Becker C, Pohl M, Thiebot M, Collin E, Hamon M, Cesselin F, et al.
Neuropharmacology
. 2000 Feb;
39(2):161-71.
PMID: 10670411
Numerous pharmacological data indirectly support the idea that interactions between cholecystokinin (CCK) and opioids participate in the development of tolerance to morphine. Biochemical investigations were performed with the aim of...
6.
Beaufour C, Ballon N, Le Bihan C, Hamon M, Thiebot M
Pharmacol Biochem Behav
. 1999 Apr;
62(4):591-9.
PMID: 10208363
The effects of chronic antidepressants were investigated in an animal procedure for the study of anxiety and anxiolytics, the conditioned suppression of operant behavior in rats. In daily 18-min sessions,...
7.
Chaperon F, Soubrie P, Puech A, Thiebot M
Psychopharmacology (Berl)
. 1998 Apr;
135(4):324-32.
PMID: 9539255
The involvement of cannabinoid processes in positive reinforcement was studied using an unbiased, one-compartment, conditioned place preference (CPP) procedure in rats. This was achieved by examining the ability of the...
8.
Arnone M, Maruani J, Chaperon F, Thiebot M, Poncelet M, Soubrie P, et al.
Psychopharmacology (Berl)
. 1997 Jul;
132(1):104-6.
PMID: 9272766
SR 141716, a selective central CB1 cannabinoid receptor antagonist, markedly and selectively reduces sucrose feeding and drinking as well as neuropeptide Y-induced sucrose drinking in rats. SR 141716 also decreases...
9.
Puech A, Thiebot M
J Psychopharmacol
. 1997 Jan;
11(3):211-8.
PMID: 9305412
This study aimed at investigating the effect of several selective serotonin reuptake inhibitors (SSRIs), given alone or in combination with anxiolytic drugs, on the time spent immobile in the forced...
10.
Bizot J, Thiebot M
Brain Res Cogn Brain Res
. 1996 Jun;
3(3-4):243-50.
PMID: 8806026
Performance in cognitive tasks which require the subject to wait and/or to process a large amount of information can be disrupted by an increase in impulsive-like behaviour. Accordingly, a decrease...